"Hiroyuki;Sugiura|Noboru;Asada|Takeru;Asano|Yasushi;Hiramatsu|Tomohiro;Urata|Toshi;Imai|Makoto;Nakamura|Kazuhiko;Yamamoto|Tatsunori;Ishikawa|Masanori;Makita|Takanori;Yoshioka|Kazutaka;Sunami|Kyosuke;Saeki|Yuichiro;Nawa|Maiko;Kimura|Makoto;Takeuchi|Masaya;Abe|Shoji;Asakura|Tomofumi;Yano|Yoshinobu;Maeda|","WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapy","Annals of Hematology","1432-0584","2026-05-09","105","7","105","","isVersionOf https://doi.org/10.1007/s00277-026-07046-5","42104158","","https://ousar.lib.okayama-u.ac.jp/70952","10.1007/s00277-026-07046-5"
    "Hiroyuki;Murakami|Ken-Ichi;Matsuoka|Takeru;Asano|Takashi;Moriyama|Akifumi;Matsumura|Hideaki;Fujiwara|Noboru;Asada|Daisuke;Ennishi|Hisakazu;Nishimori|Keiko;Fujii|Nobuharu;Fujii|Tomohiro;Toji|Tadashi;Yoshino|Yoshinobu;Maeda|","Sequential Combination of FLAM and Venetoclax plus Azacitidine to Bridge to Cord Blood Transplantation in a Patient with Primary Induction Failure Acute Myeloid Leukemia","Case Reports In Oncology","1662-6575","2022-11-08","15","3","974","979","isVersionOf https://doi.org/10.1159/000526697","36636684","000905485600025","https://ousar.lib.okayama-u.ac.jp/64314","10.1159/000526697"
    "Yusuke;Meguri|Takeru;Asano|Takanori;Yoshioka|Miki;Iwamoto|Shuntaro;Ikegawa|Hiroyuki;Sugiura|Yuriko;Kishi|Makoto;Nakamura|Yasuhisa;Sando|Takumi;Kondo|Yuichi;Sumii|Yoshinobu;Maeda|Ken-Ichi;Matsuoka|","Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation","Frontiers In Immunology","1664-3224","2022-08-02","13","","891925","","isVersionOf https://doi.org/10.3389/fimmu.2022.891925","35983059","000844642000001","https://ousar.lib.okayama-u.ac.jp/63866","10.3389/fimmu.2022.891925"
    "Takeru;Asano|Ken-ichi;Matsuoka|Satoshi;Iyama|Kazuteru;Ohashi|Yoshihiro;Inamoto|Chikako;Ohwada|Makoto;Murata|Atsushi;Satake|Chikamasa;Yoshida|Koichi;Nakase|Yasuo;Mori|Mitsune;Tanimoto|","Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease","Acta Medica Okayama","0386-300X","2016-10","70","5","429","433","","27777442","000388098700019","https://ousar.lib.okayama-u.ac.jp/54608",""